The metal chelating and chaperoning effects of clioquinol: Insights from yeast studies

Journal of Alzheimer's Disease

Volumn 21, Issue 4, 2010, Pages 1249-1262

  Li, Chenghua ^a   Wang, Juan ^a   Zhou, Bing ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Alzheimer's disease; clioquinol; homeostasis metals; yeast

Indexed keywords

CHAPERONE; CHAPERONE CCS1; CLIOQUINOL; COPPER; COPPER ION; COPPER ZINC SUPEROXIDE DISMUTASE; ENZYME; IRON; METAL; METAL CHELATE; METALLOENZYME; METALLOPROTEIN; UNCLASSIFIED DRUG; ZINC;

ANIMAL CELL; ARTICLE; BIOAVAILABILITY; CELL FUNCTION; CELL MEMBRANE; CHELATION; CONTROLLED STUDY; CYTOSOL; DRUG INHIBITION; ENZYME ACTIVITY; FUNGUS GROWTH; HOMEOSTASIS; HUMAN; HUMAN CELL; MAMMAL CELL; METAL METABOLISM; MICROARRAY ANALYSIS; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SACCHAROMYCES CEREVISIAE; YEAST; YEAST CELL;

EID: 78650480388     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100024     Document Type: Article

References (72)

1. De Freitas J, Wintz H, Kim JH, Poynton H, Fox T, Vulpe C (2003) Yeast, a model organism for iron and copper metabolism studies. Biometals 16, 185-197.
2. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM, Hartshorn MA, Tanzi RE, Bush AI (1998) Dramatic aggregation of Alzheimer Aft by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273, 12817-12826.
3. Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fair-lie DP, Tanzi RE, Bush AI (2000) Characterization of copper interactions with Alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. JNeurochem 75, 1219-1233.
4. Armendariz AD, Gonzalez M, Loguinov AV, Vulpe CD (2004) Gene expression profiling in chronic copper overload reveals upregulation of Prnp and App. Physiol Genomics 20, 45-54.
5. Bush AI, Pettingell WH, Jr., Paradis MD, Tanzi RE (1994) Modulation ofA beta adhesiveness and secretase site cleavage by zinc. J Biol Chem 269, 12152-12158.
6. Bush AI, Pettingell WH, Multhaup G, d Paradis M, Vonsattel JP, Gusella JF, Beyreuther K, Masters CL, Tanzi RE (1994) Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265, 1464-1467.
7. Ha C, Ryu J, Park CB (2007) Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template. Biochemistry 46, 6118-6125.
8. Garzon-Rodriguez W, Yatsimirsky AK, Glabe CG (1999) Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence. Bioorg Med Chem Lett 9, 2243-2248.
9. Kuperstein F, Yavin E (2002) ERK activation and nuclear translocation in amyloid-beta peptide-and iron-stressed neu-ronal cell cultures. Eur J Neurosci 16, 44-54.
10. Harris FM, Brecht WJ, Xu Q, Mahley RW, Huang Y (2004) Increased tau phosphorylation in apolipoprotein E4 trans-genic mice is associated with activation ofextracellular signal-regulated kinase: modulation by zinc. J Biol Chem 279, 44795-44801.
11. Sparks DL, Schreurs BG (2003) Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad Sci U S A 100, 11065-11069.
12. Linkous D, Adlard P, Wanschura P, Conko K, Flinn J (2009) The effects of enhanced zinc on spatial memory and plaque formation in transgenic mice. J Alzheimers Dis 18, 565-579.
13. Zhang J, Liu Q, Chen Q, Liu NQ, Li FL, Lu ZB, Qin C, Zhu H, Huang YY, He W, Zhao BL (2006) Nicotine attenuates beta-amyloid-induced neurotoxicity by regulating metal homeostasis. FASEBJ 20, 1212-1214.
14. Borchardt T, Camakaris J, Cappai R, Masters CL, Beyreuther K, Multhaup G (1999) Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion. Biochem J 344(Pt 2), 461-467.
15. Donnelly PS, Caragounis A, Du T, Laughton KM, Volitakis I, Cherny RA, Sharples RA, Hill AF, Li QX, Masters CL, Barn-ham KJ, White AR (2008) Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide. JBiol Chem 283, 4568-4577.
16. White AR, Du T, Laughton KM, Volitakis I, Sharples RA, Xilinas ME, Hoke DE, Holsinger RM, Evin G, Cherny RA, Hill AF, Barnham KJ, Li QX, Bush AI, Masters CL (2006) Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation ofmetalloprotease activity. J Biol Chem 281, 17670-17680.
17. Hoke DE, Tan JL, Ilaya NT, Culvenor JG, Smith SJ, White AR, Masters CL, Evin GM (2005) In vitro gamma-secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc. FEBSJ272, 5544-5557.
18. Crouch PJ, Hung LW, Adlard PA, Cortes M, Lal V, Filiz G, Perez KA, Nurjono M, Caragounis A, Du T, Laughton K, Voli-takis I, Bush AI, Li QX, Masters CL, Cappai R, Cherny RA, Donnelly PS, White AR, Barnham KJ (2009) Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphoryla-tion. Proc Natl Acad Sci USA 106, 381-386.
19. Phinney AL, Drisaldi B, Schmidt SD, Lugowski S, Coronado V, Liang Y, Horne P, Yang J, Sekoulidis J, Coomaraswamy J, Chishti MA, Cox DW, Mathews PM, Nixon RA, Carlson GA, St George-Hyslop P, Westaway D (2003) In vivo reduction of amyloid-beta by a mutant copper transporter. Proc Natl Acad Sci USA 100, 14193-14198.
20. Bayer TA, Schafer S, Simons A, Kemmling A, Kamer T, Tepest R, Eckert A, Schussel K, Eikenberg O, Sturchler-Pierrat C, Abramowski D, Staufenbiel M, Multhaup G (2003) Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci USA 100, 14187-14192.
21. Ding WQ, Liu B, Vaught JL, Yamauchi H, Lind SE (2005) Anticancer activity of the antibiotic clioquinol. Cancer Res 65, 3389-3395.
22. Tsubaki T, Honma Y, Hoshi M (1971) Neurological syndrome associated with clioquinol. Lancet 1, 696-697.
23. Daniel KG, Chen D, Orlu S, Cui QC, Miller FR, Dou QP (2005) Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis in-ducers in human breast cancer cells. Breast Cancer Res 7, R897-908.
24. Daniel KG, Gupta P, Harbach RH, Guida WC, Dou QP (2004) Organic copper complexes as a new class of protea-some inhibitors and apoptosis inducers in human cancer cells. Biochem Pharmacol 67, 1139-1151.
25. Mao X, Li X, Sprangers R, Wang X, Venugopal A, Wood T, Zhang Y, Kuntz DA, Coe E, Trudel S, Rose D, Batey RA, Kay LE, Schimmer AD (2009) Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma. Leukemia 23, 585-590.
26. Chen D, Cui QC, Yang H, Barrea RA, Sarkar FH, Sheng S, Yan B, Reddy GP, Dou QP (2007) Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, an-drogen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. Cancer Res 67, 1636-1644.
27. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y, Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi RE, Masters CL, Bush AI (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665-676.
28. Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, Davis S, Beyreuther K, Tanzi RE, Masters CL (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60, 1685-1691.
29. Nguyen T, Hamby A, Massa SM (2005) Clioquinol down-regulates mutant huntingtin expression in vitro and mitigates pathology in a Huntington's disease mouse model. Proc Natl Acad Sci USA 102, 11840-11845.
30. Kaur D, Yantiri F, Rajagopalan S, Kumar J, Mo JQ, Boon-plueang R, Viswanath V, Jacobs R, Yang L, Beal MF, Di-Monte D, Volitaskis I, Ellerby L, Cherny RA, Bush AI, Andersen JK (2003) Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron 37, 899-909.
31. Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, Masters CL, Targum S, Bush AI, Murdoch R, Wilson J, Ritchie CW (2008) Safety, efficacy, and biomarker findings ofPBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol 7, 779-786.
32. Bush AI (2008) Drug development based on the metals hypothesis of Alzheimer's disease. J Alzheimers Dis 15, 223240.
33. Schafer S, Pajonk FG, Multhaup G, Bayer TA (2007) Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels. JMolMed 85, 405-413.
34. Yassin MS, Ekblom J, Xilinas M, Gottfries CG, Oreland L (2000) Changes in uptake of vitamin B(12) and trace metals in brains of mice treated with clioquinol. J Neurol Sci 173, 40-44.
35. Nitzan YB, Sekler I, Frederickson CJ, Coulter DA, Balaji RV, Liang SL, Margulis A, Hershfinkel M, Silverman WF (2003) Clioquinol effects on tissue chelatable zinc in mice. J Mol Med 81, 637-644.
36. Du T, Filiz G, Caragounis A, Crouch PJ, White AR (2008) Clioquinol promotes cancer cell toxicity through tumor necrosis factor alpha release from macrophages. J Pharmacol Exp Ther 324, 360-367.
37. Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M, Volitakis I, Liu X, Smith JP, Perez K, Laughton K, Li QX, Charman SA, Nicolazzo JA, Wilkins S, Deleva K, Lynch T, Kok G, Ritchie CW, Tanzi RE, Cappai R, Masters CL, Barnham KJ, Bush AI (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59, 43-55.
38. Collart MA, Oliviero S (2001) Preparation of yeast RNA. Curr Protoc Mol Biol Chapter 13, Unit13 12.
39. Burke D, Dawson D, Stearns, T (2000) Methods in yeast genetics: a Cold Spring Harbor Laboratory course manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
40. Treiber C, Simons A, Strauss M, Hafner M, Cappai R, Bayer TA, Multhaup G (2004) Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's disease. J Biol Chem 279, 51958-51964.
41. Sanadi DR, Jacobs EE (1967) Assay of oxidative phospho-rylation at the cytochrome oxidase region (site III) Method Enzymol 10, 38-41.
42. Van Reen R (1959) Metabolic activity in calcified tissues: aconitase and isocitric dehydrogenase activities in rabbit and dog femurs. J Biol Chem 234, 1951-1954.
43. Beauchamp C, Fridovich I (1971) Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 44, 276-287.
44. Forbes JR, Cox DW (1998) Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant? Am J Hum Genet 63, 1663-1674.
45. Field LS, Furukawa Y, O'Halloran TV, Culotta VC (2003) Factors controlling the uptake of yeast copper/zinc superoxide dismutase into mitochondria. J Biol Chem 278, 28052-28059.
46. Rossi L, Ciriolo M, Marchese E, De Matino A, Giorgi M, Rotilio G (1994) Differential decrease of copper content and of copper binding to superoxide dismutase in liver, heart and brain of copper-deficient rats. Biochem Biophys Res Commun 203, 1028-1034.
47. Dancis A, Haile D, Yuan DS, Klausner RD (1994) The Sac-charomyces cerevisiae copper transport protein (Ctr1p). Biochemical characterization, regulation by copper, and physiologic role in copper uptake. J Biol Chem 269, 25660-25667.
48. Dancis A, Yuan DS, Haile D, Askwith C, Eide D, Moehle C, Kaplan J, Klausner RD (1994) Molecular characterization of a copper transport protein in S. cerevisiae: an unexpected role for copper in iron transport. Cell 76, 393-402.
49. Prohaska JR (1991) Changes in Cu,Zn-superoxide dismutase, cytochrome c oxidase, glutathione peroxidase and glutathione transferase activities in copper-deficient mice and rats. J Nutr 121, 355-363.
50. Cerone SI, Sansinanea AS, Streitenberger SA, Garcia MC, Auza NJ (2000) Cytochrome c oxidase, Cu,Zn-superoxide dismutase, and ceruloplasmin activities in copper-deficient bovines. Biol Trace Elem Res 73, 269-278.
51. Cohen E, Elvehjem, C.A. (1934) The relation of iron and copper to the cytochrome and oxidase content of animal tissues. J Biol Chem 107, 97.
52. Beinert H, Kennedy MC, Stout CD (1996) Aconitase as Iron-Sulfur Protein, Enzyme, and Iron-Regulatory Protein. Chem Rev 96, 2335-2374.
53. Wang Y, Branicky R, Stepanyan Z, Carroll M, Guimond MP, Hihi A, Hayes S, McBride K, Hekimi S (2009) The anti-neurodegeneration drug clioquinol inhibits the aging-associated protein CLK-1. J Biol Chem 284, 314-323.
54. Qiao W, Ellis C, Steffen J, Wu CY, Eide DJ (2009) Zinc status and vacuolar zinc transporters control alkaline phosphatase accumulation and activity in Saccharomyces cerevisiae. Mol Microbiol 72, 320-334.
55. Gietl C (1992) Malate dehydrogenase isoenzymes: cellular locations and role in the flow ofmetabolites between the cytoplasm and cell organelles. Biochim Biophys Acta 1100, 217234.
56. Culotta VC, Klomp LW, Strain J, Casareno RL, Krems B, Gitlin JD (1997) The copper chaperone for superoxide dismu-tase. J Biol Chem 272, 23469-23472.
57. Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, O'Halloran TV (1999) Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 284, 805-808.
58. Subramaniam JR, Lyons WE, Liu J, Bartnikas TB, Rothstein J, Price DL, Cleveland DW, Gitlin JD, Wong PC (2002) Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat Neurosci 5, 301-307.
59. Wong PC, Waggoner D, Subramaniam JR, Tessarollo L, Bart-nikas TB, Culotta VC, Price DL, Rothstein J, Gitlin JD (2000) Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc Natl Acad Sci USA 97, 2886-2891. (Pubitemid 30159267)
60. Bird AJ, Blankman E, Stillman DJ, Eide DJ, Winge DR (2004) The Zap1 transcriptional activator also acts as a repressor by binding downstream of the TATA box in ZRT2. EMBO J 23, 1123-1132.
61. Zhao H, Eide D (1996) The ZRT2 gene encodes the low affinity zinc transporter in Saccharomyces cerevisiae. J Biol Chem 271, 23203-23210.
62. Bellingham SA, Lahiri DK, Maloney B, La Fontaine S, Multhaup G, Camakaris J (2004) Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene. J Biol Chem 279, 20378-20386.
63. Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, Leiter L, McPhee J, Sarang SS, Utsuki T, Greig NH, Lahiri DK, Tanzi RE, Bush AI, Giordano T, Gullans SR (2002) An iron-responsive element type II in the 5'-untranslated region ofthe Alzheimer's amyloid precursor protein transcript. J Biol Chem 277, 45518-45528.
64. Schlief ML, Craig AM, Gitlin JD (2005) NMDAreceptor activation mediates copper homeostasis in hippocampal neurons. JNeurosci 25, 239-246.
65. Schlief ML, West T, Craig AM, Holtzman DM, Gitlin JD (2006) Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity. Proc Natl Acad Sci USA 103, 14919-14924.
66. Hirzel K, Muller U, Latal AT, Hulsmann S, Grudzinska J, Seeliger MW, Betz H, Laube B (2006) Hyperekplexia pheno-type of glycine receptor alpha1 subunit mutant mice identifies Zn(2+) as an essential endogenous modulator of glycinergic neurotransmission. Neuron 52, 679-690.
67. Takeda A, Ando M, Kanno S, Oku N (2009) Unique response ofzinc in the hippocampus to behavioral stress and attenuation of subsequent mossy fiber long-term potentiation. Neurotoxi-cology 30,712-717.
68. Adlard PA, Parncutt JM, Finkelstein DI, Bush AI Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer's disease? J Neurosci 30, 1631-1636.
69. Deshpande A, Kawai H, Metherate R, Glabe CG, Busciglio J (2009) A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses. JNeurosci 29, 4004-4015.
70. Friedlich AL, Lee JY, van Groen T, Cherny RA, Volitakis I, Cole TB, Palmiter RD, Koh JY, Bush AI (2004) Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease. J Neurosci 24, 3453-3459.
71. Lee JY, Cole TB, Palmiter RD, Suh SW, Koh JY (2002) Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci USA 99, 7705-7710.
72. Zhou LX, Du JT, Zeng ZY, Wu WH, Zhao YF, Kanazawa K, Ishizuka Y, Nemoto T, Nakanishi H, Li YM (2007) Copper (II) modulates in vitro aggregation of a tau peptide. Peptides 28, 2229-2234.